Phase I open-label trial of intraperitoneal paclitaxel in combination with intravenous cisplatin and oral capecitabine in patients with advanced gastric cancer and peritoneal metastases (IPGP study): study protocol

INTRODUCTION: Gastric cancer with peritoneal metastasis has a poor outcome. Only a few studies have specifically investigated this group of patients. Japanese researchers have shown that chemotherapy with intraperitoneal paclitaxel (IPP) and oral S-1 (tegafur/gimeracil/oteracil) is active and well t...

Descripción completa

Detalles Bibliográficos
Autores principales: Vatandoust, Sina, Bright, Tim, Roy, Amitesh Chandra, Watson, David, Gan, Susan, Bull, Jeff, Abbas, Muhammad Nazim, Karapetis, Christos Stelios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6501970/
https://www.ncbi.nlm.nih.gov/pubmed/31061042
http://dx.doi.org/10.1136/bmjopen-2018-026732

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6501970/
https://www.ncbi.nlm.nih.gov/pubmed/31061042
http://dx.doi.org/10.1136/bmjopen-2018-026732

Ejemplares similares